
Femasys Inc
NASDAQ:FEMY

Femasys Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.8
1.77
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Femasys Inc hold over its rivals?
What risks and challenges
does Femasys Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Femasys Inc.
Provide an overview of the primary business activities
of Femasys Inc.
What unique competitive advantages
does Femasys Inc hold over its rivals?
What risks and challenges
does Femasys Inc face in the near future?
Has there been any significant insider trading activity
in Femasys Inc recently?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Femasys Inc.
Provide P/S
for Femasys Inc.
Provide P/E
for Femasys Inc.
Provide P/OCF
for Femasys Inc.
Provide P/FCFE
for Femasys Inc.
Provide P/B
for Femasys Inc.
Provide EV/S
for Femasys Inc.
Provide EV/GP
for Femasys Inc.
Provide EV/EBITDA
for Femasys Inc.
Provide EV/EBIT
for Femasys Inc.
Provide EV/OCF
for Femasys Inc.
Provide EV/FCFF
for Femasys Inc.
Provide EV/IC
for Femasys Inc.
Show me price targets
for Femasys Inc made by professional analysts.
What are the Revenue projections
for Femasys Inc?
How accurate were the past Revenue estimates
for Femasys Inc?
What are the Net Income projections
for Femasys Inc?
How accurate were the past Net Income estimates
for Femasys Inc?
What are the EPS projections
for Femasys Inc?
How accurate were the past EPS estimates
for Femasys Inc?
What are the EBIT projections
for Femasys Inc?
How accurate were the past EBIT estimates
for Femasys Inc?
Compare the revenue forecasts
for Femasys Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Femasys Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Femasys Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Femasys Inc compared to its peers.
Compare the P/E ratios
of Femasys Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Femasys Inc with its peers.
Analyze the financial leverage
of Femasys Inc compared to its main competitors.
Show all profitability ratios
for Femasys Inc.
Provide ROE
for Femasys Inc.
Provide ROA
for Femasys Inc.
Provide ROIC
for Femasys Inc.
Provide ROCE
for Femasys Inc.
Provide Gross Margin
for Femasys Inc.
Provide Operating Margin
for Femasys Inc.
Provide Net Margin
for Femasys Inc.
Provide FCF Margin
for Femasys Inc.
Show all solvency ratios
for Femasys Inc.
Provide D/E Ratio
for Femasys Inc.
Provide D/A Ratio
for Femasys Inc.
Provide Interest Coverage Ratio
for Femasys Inc.
Provide Altman Z-Score Ratio
for Femasys Inc.
Provide Quick Ratio
for Femasys Inc.
Provide Current Ratio
for Femasys Inc.
Provide Cash Ratio
for Femasys Inc.
What is the historical Revenue growth
over the last 5 years for Femasys Inc?
What is the historical Net Income growth
over the last 5 years for Femasys Inc?
What is the current Free Cash Flow
of Femasys Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Femasys Inc.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
![]() |
Femasys Inc
NASDAQ:FEMY
|
23m USD | -1.4 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
230.3B USD | 22.2 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.1B USD | 59.6 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
150.7B USD | 35 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
144.1B USD | 25 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
109.6B USD | 13.2 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
52.2B EUR | 14 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
48.4B USD | 12.8 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
44.2B USD | 24.2 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.2B USD | 33.5 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
273.8B CNY | 21.5 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
![]() |
Femasys Inc
NASDAQ:FEMY
|
Average EV/EBITDA:
26.1
|
N/A | N/A | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
22.2
|
13%
|
1.7 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
59.6
|
24%
|
2.5 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
35
|
21%
|
1.7 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
25
|
12%
|
2.1 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
13.2
|
7%
|
1.9 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
14
|
14%
|
1 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
12.8
|
11%
|
1.2 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
24.2
|
12%
|
2 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
33.5
|
12%
|
2.8 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
21.5
|
16%
|
1.3 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.